XENETIC BIOSCIENCES, INC. Cash Equivalents, at Carrying Value
XENETIC BIOSCIENCES, INC. (XBIO) had Cash Equivalents, at Carrying Value of $0 as of 2013-11-30, per its 10-Q filed 2014-01-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashEquivalentsAtCarryingValue · last filed 2014-01-10
- 2013-11-30: Cash Equivalents, at Carrying Value $0.00.
- 2013-08-31: Cash Equivalents, at Carrying Value $0.00.
- 2013-05-31: Cash Equivalents, at Carrying Value $0.00.
- 2013-02-28: Cash Equivalents, at Carrying Value $0.00.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2013-11-30 | $0.00 10-Q · filed 2014-01-10 |
| 2013-08-31 | $0.00 10-K · filed 2013-11-27 |
| 2013-05-31 | $0.00 10-Q · filed 2013-07-17 |
| 2013-02-28 | $0.00 10-Q · filed 2013-04-22 |
| 2012-11-30 | $0.00 10-Q · filed 2013-01-22 |
| 2012-08-31 | $0.00 10-K · filed 2013-11-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |